NKE vs PLTR: Which Is the Better Buy?

Side-by-side comparison of NIKE, Inc. and Palantir Technologies Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-16.
NIKE, Inc. Β· Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
VS
Palantir Technologies Inc. Β· Technology
$142.76
-24.3% upside to fair value
Med Conviction Grade C
QuantHub Verdict
NKE has more upside to fair value (+45.5%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NKE PLTR
Current Price $42.62 $142.76
Fair Value Estimate $62.00 $108.00
Upside to Fair Value +45.5% -24.3%
Market Cap $63.0B $327.1B
Forward P/E 27.9x 209.7x
EV / EBITDA 20.7x β€”
Price / Sales 1.4x 73.1x
Price / FCF 19.4x 155.7x
Revenue Growth YoY -9.8% +19.1%
Gross Margin 42.7% 82.4%
Operating Margin 8.0% 31.6%
Return on Equity 24.4% 25.7%
Dividend Yield 3.8% β€”
FCF Yield 5.2% 0.6%
Analyst Consensus Buy Buy
Investment Thesis
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
PLTR β€” Palantir Technologies Inc.
Palantir Technologies develops data analytics and AI software platforms like Gotham and Foundry for government and commercial clients. The business excels with high margins (gross 82.4%, net 36.3%), accelerating growth (Q4 FY2025 revenue up 70% YoY to $1.41B, 2026 guidance $7.19B implying 61% growth), and strong moats in defense and enterprise AI, but trades expensively at 73x P/S versus 5-year m…
Accumulation Zones
Metric NKE PLTR
Zone Low $44.00 $81.00
Zone High $50.00 $92.00
In Buy Zone? Yes No
← NKE Research    PLTR Research β†’    All Research